Muscle-targeted nanoparticles strengthen the effects of small-molecule inhibitors in ameliorating sarcopenia

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet 393(10191), 2636–2646 (2019). • Proposed the definition of sarcopenia and the recommended intervention therapies of sarcopenia.
  MedlineGoogle Scholar
• 2. Petermann-Rocha F, Balntzi V, Gray SR et al. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J. Cachexia Sarcopenia Muscle 13(1), 86–99 (2022).
  MedlineGoogle Scholar
• 3. Cruz-Jentoft AJ, Landi F, Schneider SM et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age. Ageing 43(6), 748–759 (2014). • Summarized the effect of nutrition and exercise interventions in sarcopenia.
  MedlineGoogle Scholar
• 4. Colleluori G, Aguirre L, Phadnis U et al. Aerobic plus resistance exercise in obese older adults improves muscle protein synthesis and preserves myocellular quality despite weight loss. Cell. Metab. 30(2), 261–273; e266 (2019).
  Medline CASGoogle Scholar
• 5. Hurst C, Robinson SM, Witham MD et al. Resistance exercise as a treatment for sarcopenia: prescription and delivery. Age. Ageing 51(2), 1–10 (2022).
  Google Scholar
• 6. Orsso CE, Montes-Ibarra M, Findlay M et al. Mapping ongoing nutrition intervention trials in muscle, sarcopenia, and cachexia: a scoping review of future research. J. Cachexia Sarcopenia Muscle 13(3), 1442–1459 (2022).
  MedlineGoogle Scholar
• 7. Wang J, Leung KS, Chow SK, Cheung WH. Inflammation and age-associated skeletal muscle deterioration (sarcopaenia). J. Orthop. Translat. 10, 94–101 (2017).
  MedlineGoogle Scholar
• 8. Nascimento CM, Ingles M, Salvador-Pascual A, Cominetti MR, Gomez-Cabrera MC, Vina J. Sarcopenia, frailty and their prevention by exercise. Free Radic. Biol. Med. 132, 42–49 (2019).
  Medline CASGoogle Scholar
• 9. Liu Q, Yuan W, Yan Y et al. Identification of a novel small-molecule inhibitor of miR-29b attenuates muscle atrophy. Mol. Ther. Nucleic Acids 31, 527–540 (2023).
  Medline CASGoogle Scholar
• 10. Cheung A, Dantzig JA, Hollingworth S et al. A small-molecule inhibitor of skeletal muscle myosin II. Nat. Cell Biol. 4(1), 83–88 (2002).
  Medline CASGoogle Scholar
• 11. Dyle MC, Ebert SM, Cook DP et al. Systems-based discovery of tomatidine as a natural small molecule inhibitor of skeletal muscle atrophy. J. Biol. Chem. 289(21), 14913–14924 (2014).
  Medline CASGoogle Scholar
• 12. Palla AR, Ravichandran M, Wang YX et al. Inhibition of prostaglandin-degrading enzyme 15-PGDH rejuvenates aged muscle mass and strength. Science 371(6528), eabc8059 (2021). •• Found the effects of 15-PGDH inhibition (SW033291) in muscle mass and strength.
  Medline CASGoogle Scholar
• 13. Chen H, Hu B, Lv X et al. Prostaglandin E2 mediates sensory nerve regulation of bone homeostasis. Nat. Commun. 10(1), 181 (2019). • Revealed that SW033291 injection could increase PGE2 levels locally.
  MedlineGoogle Scholar
• 14. Zhang Y, Desai A, Yang SY et al. Tissue regeneration. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration. Science 348(6240), aaa2340 (2015).
  MedlineGoogle Scholar
• 15. Samoylova TI, Smith BF. Elucidation of muscle-binding peptides by phage display screening. Muscle Nerve 22(4), 460–466 (1999). • Identified a heptapeptide sequence, ASSLNIA, with enhanced in vivo muscle binding.
  Medline CASGoogle Scholar
• 16. Yu CY, Yuan Z, Cao Z et al. A muscle-targeting peptide displayed on AAV2 improves muscle tropism on systemic delivery. Gene Ther. 16(8), 953–962 (2009). • Inserted a 7-amino-acid (ASSLNIA) muscle-targeting peptide in the capsids of adeno-associated virus to enhance its tropism in muscles.
  Medline CASGoogle Scholar
• 17. Guo AY, Leung KS, Siu PM et al. Muscle mass, structural and functional investigations of senescence-accelerated mouse P8 (SAMP8). Exp. Anim. 64(4), 425–433 (2015). •• Confirmed that senescence-accelerated mouse P8 (SAMP8) mouse could be used as a sarcopenia animal model.
  Medline CASGoogle Scholar
• 18. Wang J, Cui C, Chim YN et al. Vibration and beta-hydroxy-beta-methylbutyrate treatment suppresses intramuscular fat infiltration and adipogenic differentiation in sarcopenic mice. J. Cachexia Sarcopenia Muscle 11(2), 564–577 (2020). •• Our previous study, which confirmed that SAMP8 mice were a good animal model for sarcopenia research.
  MedlineGoogle Scholar
• 19. Yu CO, Leung KS, Jiang JL, Wang TB, Chow SK, Cheung WH. Low-magnitude high-frequency vibration accelerated the foot wound healing of n5-streptozotocin-induced diabetic rats by enhancing glucose transporter 4 and blood microcirculation. Sci. Rep. 7(1), 11631 (2017).
  MedlineGoogle Scholar
• 20. Wu M, Xue L, Guo Y et al. Microenvironmentally responsive chemotherapeutic prodrugs and CHEK2 inhibitors self-assembled micelles: protecting fertility and enhancing chemotherapy. Adv. Mater. 35(11), e2210017 (2023).
  Medline CASGoogle Scholar
• 21. Jiang R, Dai J, Dong X et al. Improving image-guided surgical and immunological tumor treatment efficacy by photothermal and photodynamic therapies based on a multifunctional NIR AIEgen. Adv. Mater. 33(22), e2101158 (2021).
  Medline CASGoogle Scholar
• 22. Jia HR, Jiang YW, Zhu YX et al. Plasma membrane activatable polymeric nanotheranostics with self-enhanced light-triggered photosensitizer cellular influx for photodynamic cancer therapy. J. Control. Rel. 255, 231–241 (2017).
  Medline CASGoogle Scholar
• 23. Mohammadpour R, Dobrovolskaia MA, Cheney DL, Greish KF, Ghandehari H. Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications. Adv. Drug Deliv. Rev. 144, 112–132 (2019).
  Medline CASGoogle Scholar
• 24. Yokoyama S, Ohno Y, Egawa T et al. MBNL1-associated mitochondrial dysfunction and apoptosis in C2C12 myotubes and mouse skeletal muscle. Int. J. Mol. Sci. 21(17), 6376 (2020).
  Medline CASGoogle Scholar
• 25. Baechler BL, Bloemberg D, Quadrilatero J. Mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation. Autophagy 15(9), 1606–1619 (2019).
  Medline CASGoogle Scholar
• 26. Rubino M, Travers JG, Headrick AL et al. Inhibition of eicosanoid degradation mitigates fibrosis of the heart. Circ. Res. 132(1), 10–29 (2023).
  Medline CASGoogle Scholar
• 27. Hu B, Lv X, Chen H et al. Sensory nerves regulate mesenchymal stromal cell lineage commitment by tuning sympathetic tones. J. Clin. Invest. 130(7), 3483–3498 (2020).
  Medline CASGoogle Scholar
• 28. Hindi SM, Petrany MJ, Greenfeld E et al. Enveloped viruses pseudotyped with mammalian myogenic cell fusogens target skeletal muscle for gene delivery. Cell 186(10), 2062–2077; e2017 (2023).
  Medline CASGoogle Scholar
• 29. Studenski SA, Peters KW, Alley DE et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J. Gerontol. A. Biol. Sci. Med. Sci. 69(5), 547–558 (2014).
  MedlineGoogle Scholar
• 30. Chen LK, Woo J, Assantachai P et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J. Am. Med. Dir. Assoc. 21(3), 300–307; e302 (2020).
  MedlineGoogle Scholar
• 31. Gan Z, Fu T, Kelly DP, Vega RB. Skeletal muscle mitochondrial remodeling in exercise and diseases. Cell Res. 28(10), 969–980 (2018).
  Medline CASGoogle Scholar
• 32. Sebastian D, Sorianello E, Segales J et al. Mfn2 deficiency links age-related sarcopenia and impaired autophagy to activation of an adaptive mitophagy pathway. EMBO J. 35(15), 1677–1693 (2016).
  Medline CASGoogle Scholar
• 33. Marcangeli V, Youssef L, Dulac M et al. Impact of high-intensity interval training with or without L-citrulline on physical performance, skeletal muscle, and adipose tissue in obese older adults. J. Cachexia Sarcopenia Muscle 13(3), 1526–1540 (2022).
  MedlineGoogle Scholar
• 34. Romanello V, Sandri M. Mitochondrial quality control and muscle mass maintenance. Front. Physiol. 6, 422 (2015).
  MedlineGoogle Scholar
• 35. Leduc-Gaudet JP, Picard M, St-Jean Pelletier F et al. Mitochondrial morphology is altered in atrophied skeletal muscle of aged mice. Oncotarget 6(20), 17923–17937 (2015).
  MedlineGoogle Scholar
• 36. Barnthaler T, Theiler A, Zabini D et al. Inhibiting eicosanoid degradation exerts antifibrotic effects in a pulmonary fibrosis mouse model and human tissue. J. Allergy Clin. Immunol. 145(3), 818–833; e811 (2020).
  MedlineGoogle Scholar
• 37. Cheng H, Huang H, Guo Z, Chang Y, Li Z. Role of prostaglandin E2 in tissue repair and regeneration. Theranostics 11(18), 8836–8854 (2021).
  Medline CASGoogle Scholar
• 38. Shirvani-Farsani Z, Behmanesh M, Mohammadi SM, Naser Moghadasi A. Vitamin D levels in multiple sclerosis patients: association with TGF-beta2, TGF-betaRI, and TGF-betaRII expression. Life Sci. 134, 63–67 (2015).
  Medline CASGoogle Scholar
• 39. Dong Y, Li Y, Zhang C, Chen H, Liu L, Chen S. Effects of SW033291 on the myogenesis of muscle-derived stem cells and muscle regeneration. Stem Cell Res. Ther. 11(1), 76 (2020).
  Medline CASGoogle Scholar